Abstract
Erratum: Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have